Download PDF
Thromb Haemost 2009; 101(04): 605-606
DOI: 10.1160/TH09-02-0088
Editorial Focus
Schattauer GmbH

Matrix-Gla protein and vascular calcification: The negative role of oral anticoagulant therapy

Mario Cozzolino
1   Renal Division, S. Paolo Hospital, University of Milan, Milan, Italy
› Author Affiliations
Further Information

Publication History



Accepted: 09 February 2009

Publication Date:
23 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Koos R, Krueger T, Westenfeld R. et al. Relation of circulating matrix Gla-protein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost 2009; 101: 706-713.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Cozzolino M, Brancaccio D, Gallieni M. et al. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 2005; 68: 429-436.
    CrossrefPubMedGoogle Scholar
  • 3 Cozzolino M, Mazzaferro S, Pugliese F. et al. Vascular calcification and uremia: what do we know?. Am J Nephrol 2008; 28: 339-346.
    CrossrefPubMedGoogle Scholar
  • 4 Luo G, Ducy P, McKee MD. et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81.
    CrossrefPubMedGoogle Scholar
  • 5 Shearer MJ. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 2000; 3: 433-438.
    CrossrefPubMedGoogle Scholar
  • 6 Zebboudj AF, Shin V, Bostrom K. Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 2003; 90: 756-765.
    CrossrefPubMedGoogle Scholar
  • 7 Canfield AE, Farrington C, Dziobon MD. et al. The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study. J Pathol 2002; 196: 228-234.
    CrossrefPubMedGoogle Scholar
  • 8 Jono S, Ikari Y, Vermeer C. et al. Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography. Thromb Haemost 2004; 91: 790-794.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Hermann S-M, Whatling C, Brand E. et al. Polymorphisms of the human matrix Gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol 2000; 20: 2386-2393.
    CrossrefPubMedGoogle Scholar
  • 10 Brancaccio D, Biondi ML, Gallieni M. et al. Matrix gla protein gene polymorphisms and cardiovascular mortality in chronic kidney disease patients. Am J Nephrol 2005; 25: 548-552.
    CrossrefPubMedGoogle Scholar
  • 11 Schurgers LJ, Cranenburg ECM, Vermeer C. Matrix-Gla-protein: The calcification inhibitor in need of vitamin K. Thromb Haemost 2008; 100: 593-603.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Cranenburg EC, Schurgers LJ, Vermeer C. Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost 2007; 98: 120-125.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Price PA, Lim JE. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem 2003; 278: 22144-22152.
    CrossrefPubMedGoogle Scholar
  • 14 Price PA, Caputo JM, Williamson MK. Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. J Bone Miner Res 2002; 17: 1171-1179.
    CrossrefPubMedGoogle Scholar